Related Experiment Videos
Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy
Circulation
|September 1, 1981
Insights
Verapamil effectively treats hypertrophic cardiomyopathy but can cause serious adverse effects. Understanding these risks helps minimize complications in patients undergoing verapamil treatment.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
- Verapamil is a calcium channel blocker used in HCM management.
Purpose of the Study:
- To highlight the efficacy of verapamil in treating hypertrophic cardiomyopathy.
- To elucidate the potential serious adverse effects associated with verapamil therapy.
- To guide clinicians in minimizing verapamil-induced complications in HCM patients.
Main Methods:
- Review of physiological actions of verapamil.
- Analysis of adverse event profiles in hypertrophic cardiomyopathy patients.
- Clinical data interpretation regarding verapamil's safety and efficacy.
Main Results:
- Verapamil demonstrates significant effectiveness in managing hypertrophic cardiomyopathy.
- The drug's physiological mechanisms can precipitate severe adverse events.
- Specific conditions increase the likelihood of these complications.
Conclusions:
- Verapamil is a valuable therapeutic agent for hypertrophic cardiomyopathy.
- Awareness of verapamil's adverse effects is crucial for patient safety.
- Proactive management strategies can mitigate risks in verapamil-treated HCM patients.
Abstract:
Verapamil is extremely effective in the treatment of patients with hypertrophic cardiomyopathy. However, the basic physiologic actions of the drug may lead to serious adverse effects. An appreciation of this and an understanding of when these adverse effects are most likely to occur will minimize the potential of verapamil to cause serious complications in patients with hypertrophic cardiomyopathy.